XuanZhu Pharma is a biopharmaceutical company that focuses on drug research and development.
XuanZhu Pharma is an innovative biopharmaceutical company rooted in China, with a global perspective, focusing on tumors, metabolic diseases, infections, and other fields. It has a layout of the entire industry chain from drug discovery, preclinical research, clinical development, and production and sales.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 31, 2021 | Series B | ¥610.50M | 6 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Jinjiang Xuanhong Equity Investment | — | Series B |
BOC Capital | — | Series B |
Financial Holding Group | — | Series B |
Hainan Wanxin Private Equity Fund Management | — | Series B |
Hai Chuang Fund of Funds | — | Series B |
Shaanxi Financial Holding Group | — | Series B |